4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514258, 514260, 514259, A61K 31505, A61K 3152

Patent

active

056397577

ABSTRACT:
Certain 4-aminopyrrolo[2,3-d]pyrimidine compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and are useful for immunoregulation and for the treatment of cancer, angiogenesis and atherosclerosis.

REFERENCES:
patent: 5036071 (1991-07-01), Johansson et al.
patent: 5457105 (1995-10-01), Barker
patent: 5475001 (1995-12-01), Barker
Chemical Abstracts 111:39290e, "Synthesis and Biological Activity of Pyrrolo [2,3-d] Pyrimidines", Dave et al. Aug. 1988.
Chaitanya, G. Dave. Indian Journal of Chemistry vol. 27B, Aug. 1988, pp. 778-780, "Synthesis & Biological Activity of Pyrrolo[2,3-d]pyrimidinest".
Chaitanya, G. Dave. Indian Journal of Chemistry 64, 713 (1987) pp. 713-715, "Pyrrolo[2,3-d]pyrimidines. Synthesis and Reaction of 2-Amino-3-cyanopyrroles".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2157965

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.